Literature DB >> 1350261

c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis.

J Chen1, C Compton, E Cheng, F Fromowitz, M V Viola.   

Abstract

A sensitive restriction fragment length polymorphism assay and DNA sequencing were used to detect c-Ki-ras mutations in 56 specimens of colonic epithelium from 18 patients with chronic ulcerative colitis. Mutations were not detected in biopsy specimens that were negative or indefinite for dysplasia. In 4 of 8 patients with high-grade dysplasia, a c-Ki-ras codon 12 or 13 mutation was detected. In three colectomy specimens, a wide area of dysplastic cells (greater than 10 cm2) contained a specific ras mutation. In two of these specimens, an invasive cancer contained a c-Ki-ras mutation identical to that found in adjacent dysplastic epithelium. These studies indicate that mutations of c-Ki-ras may be an excellent molecular genetic marker to map dysplastic fields and invasive cancer in ulcerative colitis.

Entities:  

Mesh:

Year:  1992        PMID: 1350261     DOI: 10.1016/0016-5085(92)90323-q

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

2.  DPC4 gene mutation in colitis associated neoplasia.

Authors:  A T Hoque; S A Hahn; M Schutte; S E Kern
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations.

Authors:  S N Andersen; T Lovig; O P Clausen; A Bakka; O Fausa; T O Rognum
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

4.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 5.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

6.  Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

Authors:  C A Cartwright; C A Coad; B M Egbert
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

7.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

8.  Analysis of signaling protein kinases in human colon or colorectal carcinomas.

Authors:  L L Licato; D A Brenner
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

9.  Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer.

Authors:  Earl Gillespie; Susan E Leeman; Luisa A Watts; Jennifer A Coukos; Michael J O'Brien; Sandra R Cerda; Francis A Farraye; Arthur F Stucchi
Journal:  J Crohns Colitis       Date:  2012-08-23       Impact factor: 9.071

10.  Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis.

Authors:  M G Thomas; K P Nugent; A Forbes; R C Williamson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.